Used as a key chiral intermediate in the synthesis of pharmaceutical agents, particularly in the development of kinase inhibitors for targeted cancer therapies. Its structural features enable high selectivity and binding affinity to specific enzyme targets, enhancing drug efficacy. The compound's stereochemistry plays a critical role in biological activity, making it valuable in asymmetric synthesis routes for active pharmaceutical ingredients (APIs). It is also employed in research settings to optimize metabolic stability and bioavailability in new drug candidates.